Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 181 AL 195

Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects

Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE.

Inflammopharmacology. 2023 Jun;31(3):1107-1115. doi: 10.1007/s10787-023-01163-7. Epub 2023 Feb 28.

Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois B, López-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators.

Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x.

Lecanemab: First Approval

Hoy SM.

Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2.

Insights on benzodiazepines' potential in Alzheimer's disease

Al-Kuraishy HM, Al-Gareeb AI, Alsayegh AA, Abusudah WF, Almohmadi NH, Eldahshan OA, Ahmed EA, Batiha GE.

Life Sci. 2023 May 1;320:121532. doi: 10.1016/j.lfs.2023.121532. Epub 2023 Feb 28.

[Therapeutic potential of targeting SIRT1 for the treatment of Alzheimer's disease]

Shen LL, Sun HY, Wang HQ.

Sheng Li Xue Bao. 2023 Feb 25;75(1):99-107.

The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double-blind, controlled trial

Tamtaji OR, Heidari-Soureshjani R, Asemi Z, Kouchaki E.

Phytother Res. 2023 Jul;37(7):2957-2964. doi: 10.1002/ptr.7791. Epub 2023 Mar 2.

Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D

Kouba BR, Camargo A, Rodrigues ALS.

Metab Brain Dis. 2023 Mar;38(3):819-829. doi: 10.1007/s11011-023-01188-5. Epub 2023 Mar 2.

Traditional Chinese Patent Medicine in the Treatment of Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

Liu C, Zhang L, Li Y, Li M, Han H, Wang K.

Am J Chin Med. 2023;51(3):517-546. doi: 10.1142/S0192415X2350026X. Epub 2023 Feb 28.

Induced human pluripotent stem cells (HEBHMUi013-A) derived from a patient of sporadic Alzheimer's disease

Cao S, Guo R, Fu Z, Liu Y, Wu T, Zhou Z, Zhang J, Liu X, Song Y, Ma J.

Stem Cell Res. 2023 Apr;68:103052. doi: 10.1016/j.scr.2023.103052. Epub 2023 Mar 2.

Inhibition of ferroptosis through regulating neuronal calcium homeostasis: An emerging therapeutic target for Alzheimer's disease

Sun 孙意冉 Y, Yan C, He L, Xiang S, Wang P, Li Z, Chen Y, Zhao J, Yuan Y, Wang W, Zhang X, Su P, Su Y, Ma J, Xu J, Peng Q, Ma H, Xie Z, Zhang Z.

Ageing Res Rev. 2023 Jun;87:101899. doi: 10.1016/j.arr.2023.101899. Epub 2023 Mar 4.

Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease

Susmitha G, Kumar R.

Neuropharmacology. 2023 May 15;229:109478. doi: 10.1016/j.neuropharm.2023.109478. Epub 2023 Mar 5.

Mitochondrial mechanisms in Alzheimer's disease: Quest for therapeutics

Kalani K, Chaturvedi P, Chaturvedi P, Kumar Verma V, Lal N, Awasthi SK, Kalani A.

Drug Discov Today. 2023 May;28(5):103547. doi: 10.1016/j.drudis.2023.103547. Epub 2023 Mar 5.

Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models

Ferré-González L, Lloret A, Cháfer-Pericás C.

Prog Lipid Res. 2023 Apr;90:101223. doi: 10.1016/j.plipres.2023.101223. Epub 2023 Mar 5.

Cellular response to β-amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics

Zhang H, Li X, Wang X, Xu J, Elefant F, Wang J.

Animal Model Exp Med. 2023 Feb;6(1):3-9. doi: 10.1002/ame2.12313.

Is type 2 diabetes associated dementia a microvascular early-Alzheimer's phenotype induced by aberrations in the peripheral metabolism of lipoprotein-amyloid?

Takechi R, Sharif A, Brook E, Majimbi M, Chan DC, Lam V, Watts GF, Mamo JCL.

Front Endocrinol (Lausanne). 2023 Feb 16;14:1127481. doi: 10.3389/fendo.2023.1127481. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias